StockWatch
·
Pharmaceuticals
Insider Trading29 Jun 2026, 06:20 pm

Fermenta Biotech Closes Trading Window from July 1, 2026

AI Summary

Fermenta Biotech Ltd has announced the closure of its trading window from July 01, 2026, until 48 hours after the announcement of its unaudited financial results for the quarter ending June 30, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. During this period, directors, promoters, insiders, and designated persons, including auditors, are prohibited from trading in the company's securities. The specific date of the board meeting to approve the financial results will be announced in due course. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.

Key Highlights

  • Trading window closed from July 1, 2026, for Q1 FY27 results.
  • Prohibits trading by directors, promoters, and insiders.
  • Aims to prevent insider trading as per SEBI regulations.
  • Closure lasts until 48 hours post financial results announcement.